Cargando…
Novel forms of injectable buprenorphine and French model of opioid use disorder treatment
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Masson SAS on behalf of Société française de pharmacologie et de thérapeutique.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521403/ https://www.ncbi.nlm.nih.gov/pubmed/33039103 http://dx.doi.org/10.1016/j.therap.2020.09.007 |
_version_ | 1783587972195549184 |
---|---|
author | Lapeyre-Mestre, Maryse |
author_facet | Lapeyre-Mestre, Maryse |
author_sort | Lapeyre-Mestre, Maryse |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7521403 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Published by Elsevier Masson SAS on behalf of Société française de pharmacologie et de thérapeutique. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75214032020-09-29 Novel forms of injectable buprenorphine and French model of opioid use disorder treatment Lapeyre-Mestre, Maryse Therapie Editorial Published by Elsevier Masson SAS on behalf of Société française de pharmacologie et de thérapeutique. 2020 2020-09-28 /pmc/articles/PMC7521403/ /pubmed/33039103 http://dx.doi.org/10.1016/j.therap.2020.09.007 Text en © 2020 Published by Elsevier Masson SAS on behalf of Société française de pharmacologie et de thérapeutique. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Editorial Lapeyre-Mestre, Maryse Novel forms of injectable buprenorphine and French model of opioid use disorder treatment |
title | Novel forms of injectable buprenorphine and French model of opioid use disorder treatment |
title_full | Novel forms of injectable buprenorphine and French model of opioid use disorder treatment |
title_fullStr | Novel forms of injectable buprenorphine and French model of opioid use disorder treatment |
title_full_unstemmed | Novel forms of injectable buprenorphine and French model of opioid use disorder treatment |
title_short | Novel forms of injectable buprenorphine and French model of opioid use disorder treatment |
title_sort | novel forms of injectable buprenorphine and french model of opioid use disorder treatment |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521403/ https://www.ncbi.nlm.nih.gov/pubmed/33039103 http://dx.doi.org/10.1016/j.therap.2020.09.007 |
work_keys_str_mv | AT lapeyremestremaryse novelformsofinjectablebuprenorphineandfrenchmodelofopioidusedisordertreatment |